Severe acute pancreatitis occurs in 15-25% of 
INTRODUCTION
Severe acute pancreatitis occurs when local and/or systemic complications (organ failure) develop. It affects approximately 15-25% of all patients with acute pancreatitis (AP), and has a dismal prognosis with overall mortality rate about 2%, remaining much higher in subgroups of patients with severe disease (Fagenholz et al., 2007) . Different scoring systems with many specific prognostic parameters and risk factors have been developed with the intention of ability to early predict severe acute pancreatitis. This could provide rapid identification and resuscitation of patients with impending severe course of disease.
Some studies can be found on body composition analysis of acute pancreatitis patients. Most of them, based on BMI and/or waist circumference measurements, concluded that adiposity is a risk factor of severe acute pancreatitis and mortality (De Waele et al., 2006; Martinez et al., 2006; Wang et al., 2011; O'Leary et al., 2012; Katuchova et al., 2014; Sawalhi et al., 2014) . From another point of view obesity is a risk factor for acute pancreatitis (Blomgren et al., 2002) .
Several studies have looked at the importance of adipose tissue distribution (Beasley et al., 2009; Duarte-Rojo et al., 2010) measured by computed tomography (CT) scans. Visceral adiposity has been identified as risk factor for more severe acute pancreatitis. Less data can be found about amount of intramuscular fat and its impact on acute pancreatitis. Adipose tissue depots in the abdominal cavity and in muscles have been associated with chronic inflammation, as well with impaired glucose tolerance, increased cholesterol level and decreased strength (Prior et al., 2007; Durheim et al., 2008; Koster et al., 2010; Addison et al., 2011; Dube et al., 2011; Tuttle et al., 2011; Tuttle et al., 2012) .
Computed tomography is a promising reference method for the differentiation and quantification of various soft tissue depots (Pascot et al., 1999; Goodpaster et al., 2003; Good- PROCEEDINGS OF THE LATVIAN ACADEMY OF SCIENCES. Section B, Vol. 72 (2018 ), No. 2 (713), pp. 43-48. DOI: 10.2478 /prolas-2018 IMPACT OF BODY COMPOSITION, MEASURED BY COMPUTED TOMOGRAPHY SCAN, ON ACUTE PANCREATITIS COURSE paster et al., 2005; Johnson et al., 2006) and have been used already in clinical studies on the impact of body composition alterations in many diseases and effect of aging on clinical outcomes. Visceral, subcutaneous, intramuscular adipose and muscular tissue areas can be measured per Hounsfield unit segmentation thresholds. Also, CT scan measurements can provide estimates of total fat mass, total lean body mass, fat and lean body mass indices (normalised for stature), subcutaneous fat-to-muscle ratio and visceralto-subcutaneous adipose tissue ratio (Mitsiopoulos et al., 1998; Mourtzakis et al., 2008; Yip et al., 2015) .
However, little is known about malnutrition or underweight and acute pancreatitis. Alcohol abuse is a part of the aetiology of acute pancreatitis, and it can cause also malnutrition. Also, various chronic diseases, such as diabetes mellitus and chronic obstructive pulmonary disease, as comorbidities to acute pancreatitis, can be associated with risk of body composition alterations. It seems that underweight also predict the more severe pancreatitis and higher mortality risk (Taguchi et al., 2014) , anyway no data is found about impact of sarcopenia (involuntary loss of skeletal muscle mass and/or strength) or sarcopenic adiposity in acute pancreatitis course.
The aim of our study was to analyse body composition (muscle mass, adipose tissue distribution), measured by CT scans, in acute pancreatitis patients, and determine its impact on disease severity.
MATERIALS AND METHODS
A total of 100 patients were included in the study prospectively from January 2015 till April 2016. Patient inclusion criteria were: 1) ³ 18 years old; 2) approved participation in the study; 3) diagnosis of acute pancreatitis, and 4) underwent abdominal CT. Acute pancreatitis was diagnosed based on two criteria of three as follows: the presence of typical abdominal pain (the cardinal symptom of acute pancreatitis), serum amylase or lipase levels threefold or more above the upper normal limit, abdominal CT scan findings compatible with acute pancreatitis (Banks et al., 2013) . Patients were excluded if consent of participation in the study was not given or if they had not had a CT. We recorded data about patient age, gender, height, and body weight at admission, pancreatitis aetiology, severity of acute pancreatitis, hospitalisation days, and mortality. The study protocol was approved by the Ethics Committee of Pauls Stradiòð Clinical University Hospital.
Patients were stratified by body-mass index (BMI, kg/m²) according to the WHO classification (Anonymous, 1995) with cut-offs being 18.5, 23, 25, 27.5, 30, 32.5, 35, 37.5 , and 40 kg·m -2 .
Computed tomography scan was used in the study to assess body composition and measure adipose tissue and muscles areas. The software ImageJ v1.42q (National Institutes of Health Bethesda, Maryland, USA) was used for CT image analysis. The third lumbar vertebra was selected for the standard landmark measurements. Muscles were assessed based on their anatomical characteristics and structure, using a Hounsfielda unit (HU) range from (-29) to 150. The muscle cross-sectional area (cm 2 ) was measured for each patient. The HU thresholds used for adipose tissues were (-190) to (-30) . Tissue boundaries were manually corrected as needed. Cross-sectional areas (cm 2 ) were calculated automatically by summing tissue pixels and multiplying by pixel surface area. The skeletal muscle index L3 (cm 2 ·m -2 ) was estimated as the ratio between area of skeletal muscle at L3 vertebra level and the patient's height squared (m 2 ).
Sarcopenia was recorded in cases when the ratio for men was under 52.4 cm 2 ·m -2 and for women under 38.5 cm 2 ·m -2 . Adipose tissue distribution (visceral fat, subcutaneous and intramuscular fat areas) was measured and the adipose tissue index was calculated as for the skeletal muscle index. The impacts of these factors on pancreatitis course were analysed.
The severity of AP was defined in accordance with the Atlanta Criteria: mild acute pancreatitis with no organ failure, local or systemic complications; moderately severe acute pancreatitis defined by the presence of transient organ failure, local complications or exacerbation of co-morbid disease; and severe acute pancreatitis defined by persistent organ failure, that is, organ failure >48 h. Local complications included in the analysis were peripancreatic fluid collections, pancreatic and peripancreatic necrosis (sterile or infected), pseudocyst and walled-off necrosis (sterile or infected) (Banks et al., 2012) .
Statistical analysis was performed with IBM SPSS Statistics 23. The Chi square test, t-test and general linear model were used. The significance level was set as a = 0.05. When p £ 0.05, the difference was considered statistically significant.
RESULTS
Of the included 100 patients, 42 (42%) were females and 58 (58%) were males. Mean age was 51 (range 18-92).
Aetiologic factors were: biliary pancreatitis -23 (23%), alcohol -58 (58%), post-ERCP -4 (4%), hypertriglyceridemia -4 (4%), and idiopathic -12 (12%). Most of patients received conservative treatment (78 cases; 78%), endoscopical treatment was applied in 8 (8%) cases, and drainage surgery in 14 (14%). Moderately severe acute pancreatitis occurred in 83% (83 patients) cases and severe pancreatitis in 17% (17 patients), no mild pancreatitis cases were included. Mortality was 6% (6 patients). Mean hospital time was 13 days (range 3 till 139) ( Table 1) .
Normal weight according to BMI occurred in 38% (38 patients), overweight in 33% (33 patients), and obesity in 28% (28 patients) cases; one patient was underweight. Mean values of soft tissue areas by CT measurements are showed in Table 2 .
Overall sarcopenia was detected in 51 patients (51%). According to BMI, sarcopenia was detected in one underweight patient, in 25 patients (67%) with normal weight, in 16 patients (47%) who were overweight, and in 9 obese patients (32%) ( Table 3) .
Sarcopenia was found in six patients (35%) with severe pancreatitis and in 45 patients (54%) with moderately severe pancreatitis.
Univariate analysis showed significant difference between groups of moderately severe and severe acute pancreatitis in intramuscular fat area (p = 0.022), and occurrence of obesity (p = 0.026) and nonsignificant for sarcopenia (p = 0.064).
A general linear model was used to estimate the occurrence of severe pancreatitis based on sarcopenia as a random factor and age as covariate. The model showed that none of the independent variables had a statistically significant effect on the occurrence of severe pancreatitis (p = 0.095 and 0.154, sarcopenia and age, respectively). Also, the model was used to test whether obesity had a significant association with severe pancreatitis, taking patient's age into account (as a covariate). The model showed that obesity had a significant (p = 0.026) effect on the occurrence of severe pancreatitis while age was not a significant factor (p = 0.208).
A general linear model between sarcopenia, sarcopenic adiposity and visceral, subcutaneous, total fat indexes, and intramuscular fat area showed that only intramuscular fat area had a significant effect on the occurrence of severe pancreatitis (p = 0.029).
As mean values of intramuscular fat area were 10.00 cm 2 in moderately severe and 15.81 cm 2 in severe pancreatitis, it was proposed that higher value of intramuscular fat area increases risk of severe acute pancreatitis. An area under the ROC (receiver operating characteristic) curve was 0.689 and intramuscular fat area 11 cm 2 was considered as the threshold at which the probability of severe pancreatitis increases.
DISCUSSION
The present study investigated association between body composition analysis by CT scan and acute pancreatitis severity. Our study results showed that obesity was a risk fac- tor of severe pancreatitis and that higher intramuscular fat area likely was another risk factor.
Obesity as a risk factor of severe acute pancreatitis is consistent with findings of other studies (De Waele et al., 2006 : Martinez et al., 2006 Wang et al., 2011; O'Leary et al., 2012; Katuchova et al., 2014; Sawalhi et al., 2014; Thandassery et al., 2014 , Hall et al., 2015 .
Still, neither the sarcopenia, nor sacropenic adiposity, were observed to be associated with higher risk of severe pancreatitis in our study.
Analysis of abdominal fat distribution using computer software based on CT images has been addressed in many studies till now. Nevertheless, conflicting conclusions of different studies have been reported (Mery et al., 2002; O'Leary et al., 2012; Hall et al., 2015) . Fat depots in the abdominal cavity or the liver have higher systemic levels of proinflammatory cytokines (Malavazos et al., 2007; Chalasani et al., 2012) . Patel et al. observed that unsaturated fatty acids generated via lipolysis of visceral fat by pancreatic lipases are associated with severe acute pancreatitis, independently of pancreatic necrosis and the inflammatory response (Patel et al., 2015) .
Several studies have suggested that intramuscular adipose tissue may release proinflammatory cytokines, which results in local inflammation (Zoico et al., 2010; Koster et al., 2011; Addison et al., 2015) . Beasley et al. (2009) suggested that intramuscular adipose tissue may be related, also, to increased systemic body inflammation, and showed a relationship between the amount of intramuscular adipose tissue within the thigh and systemic measures of proinflammatory cytokines in the serum.
Our results did not show significant effect of visceral fat depots on severe acute pancreatitis; the subcutaneous fat amount also did not have significant effect. However, intramuscular fat area had significant effect on risk of severe acute pancreatitis (p value = 0.029). However, the area under the ROC curve was 0.689, which suggests that increased intramuscular fat amount is associated with more severe acute pancreatitis, and the threshold was estimated to be 11 cm 2 . However, a larger patient cohort is needed to provide a more precise estimation of the threshold. We could not find similar data in the literature about this association with the amount of intramuscular adipose tissue. We suggest that this threshold of area or some index could be defined as a pathologic state with substantial impact on health.
Various techniques like dual-energy X-ray absorptiometry, bioelectrical impedance analysis, CT and magnetic resonance imaging can be used to estimate body composition.
CT is a diagnostic technique that is often used in patients with inflammatory diseases or in an area of oncology. CT has shown high accuracy in body composition evaluation (Mourtzakis et al., 2008; Gibson et al., 2015) . Therefore, gaining additional information through body composition analysis from CT imaging data can provide an opportunity to integrate supportive care in nutrition or rehabilitation. This procedure can be done even for severely ill patients with poor overall status without any extra investigations (Brewster et al., 2014) .
Also, measurement of body composition by CT scans gives more precise data about nutrition status than just BMI. In our patient group, only one patient was underweight by BMI and 51% had sarcopenia.
A limitation of this study was lack of patient with mild pancreatitis. CTs were done for patients with the need for recheck of diagnoses or because complications were suspected. Increase of patient cohort size might give more significant data about effect of fat distribution on severe pancreatitis risk, as a small number of patients were in the severe pancreatitis category.
In conclusion, body composition analysis can be done in moderately severe and severe acute pancreatitis patients by CT imagery. Body composition analysis showed that adiposity is a risk factor of severe acute pancreatitis, and likely higher intramuscular fat area is another risk factor. 
